Martin Williams

Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)

B. Meldrum, A. Chapman, K. Nanan, 2000, Neuropharmacology.

The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample

M. Barratt, A. Winstock, W. Lawn, 2014, Journal of psychopharmacology.

Should addiction researchers be interested in psychedelic science?

D. Caldicott, Martin Williams, Stephen J. Bright, 2017, Drug and alcohol review.

Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm

G. Murray, C. Loo, M. Berk, 2021, The Australian and New Zealand journal of psychiatry.

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.

Martin Williams, C. O’Callaghan, M. Ross, 2020, Journal of music therapy.

Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead

P. Fitzgerald, J. Bennett-Levy, P. Puspanathan, 2021, Frontiers in Psychiatry.

Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research

Martin Williams, Stephen J. Bright, S. Bright, 2018, Australian Psychologist.

Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models

B. Oldfield, C. Foldi, Martin Williams, 2020, Frontiers in Neuroscience.